rs16935244

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000524555.3(SAA2-SAA4):​c.230+1171A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0309 in 152,234 control chromosomes in the GnomAD database, including 252 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.031 ( 252 hom., cov: 33)

Consequence

SAA2-SAA4
ENST00000524555.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0370

Publications

1 publications found
Variant links:
Genes affected
SAA2-SAA4 (HGNC:39550): (SAA2-SAA4 readthrough) This locus represents naturally occurring read-through transcription between the neighboring serum amyloid A2 and serum amyloid A4 genes on chromosome 11. The read-through transcript produces a fusion protein that shares sequence identity with each individual gene product. [provided by RefSeq, Dec 2010]
SAA2 (HGNC:10514): (serum amyloid A2) This gene encodes a member of the serum amyloid A family of apolipoproteins. The encoded preproprotein is proteolytically processed to generate the mature protein. This protein is a major acute phase protein that is highly expressed in response to inflammation and tissue injury. This protein also plays an important role in HDL metabolism and cholesterol homeostasis. High levels of this protein are associated with chronic inflammatory diseases including atherosclerosis, rheumatoid arthritis, Alzheimer's disease and Crohn's disease. This protein may also be a potential biomarker for certain tumors. Finally, antimicrobial activity against S. aureus and E. coli resides in the N-terminal portion of the mature protein. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SAA2-SAA4NM_001199744.2 linkc.230+1171A>G intron_variant Intron 3 of 5 NP_001186673.1 A0A096LPE2
SAA2NM_001127380.3 linkc.230+1171A>G intron_variant Intron 3 of 3 NP_001120852.1 P0DJI9-2
SAA2NM_001385667.1 linkc.230+1171A>G intron_variant Intron 4 of 4 NP_001372596.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SAA2-SAA4ENST00000524555.3 linkc.230+1171A>G intron_variant Intron 3 of 5 3 ENSP00000485552.1 A0A096LPE2
SAA2ENST00000414546.6 linkc.230+1171A>G intron_variant Intron 3 of 3 1 ENSP00000416716.2 P0DJI9-2
SAA2ENST00000528349.5 linkc.230+1171A>G intron_variant Intron 3 of 3 2 ENSP00000435659.1 G3V1D9
SAA2ENST00000530400.5 linkc.230+1171A>G intron_variant Intron 2 of 2 3 ENSP00000432370.1 E9PR14

Frequencies

GnomAD3 genomes
AF:
0.0309
AC:
4695
AN:
152116
Hom.:
253
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.107
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000544
Gnomad OTH
AF:
0.0248
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0309
AC:
4698
AN:
152234
Hom.:
252
Cov.:
33
AF XY:
0.0299
AC XY:
2224
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.107
AC:
4425
AN:
41502
American (AMR)
AF:
0.0118
AC:
180
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000544
AC:
37
AN:
68020
Other (OTH)
AF:
0.0246
AC:
52
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
214
428
642
856
1070
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0395
Hom.:
187
Bravo
AF:
0.0361
Asia WGS
AF:
0.00318
AC:
11
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.9
DANN
Benign
0.72
PhyloP100
-0.037
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16935244; hg19: chr11-18266286; API